(Q41731111)

8 October 2017

title

5-Hydroxymethylcytosine, the "Sixth Base", during brain development and ageing (English)

1 reference

8 October 2017

Theo F J Kraus

1

1 reference

8 October 2017

Virginie Guibourt

series ordinal

2

1 reference

8 October 2017

Hans A Kretzschmar

series ordinal

3

1 reference

8 October 2017

publication date

4 December 2014

1 reference

Journal of Neural Transmission

8 October 2017

published in

1 reference

8 October 2017

volume

122

1 reference

8 October 2017

issue

7

1 reference

8 October 2017

page(s)

1035-1043

1 reference

Epigenetic changes in the progression of Alzheimer's disease

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Web-based method for translating neurodevelopment from laboratory species to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Genomic mapping of 5-hydroxymethylcytosine in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

5-Hydroxymethylcytosine, the sixth base of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Neocortical glial cell numbers in human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

The discovery of 5-formylcytosine in embryonic stem cell DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1346-4

Uncovering the role of 5-hydroxymethylcytosine in the epigenome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25471351

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25471351

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00702-014-1346-4

1 reference

Dimensions Publication ID

8 October 2017

1029603525

0 references

1 reference